261 studies found for:
Lipid Storage Diseases
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 |
Completed
Has Results |
Stem Cell Transplant for Inborn Errors of Metabolism
|
||||
| 22 | Enrolling by invitation |
Identification of Undiagnosed Lysosomal Acid Lipase Deficiency
|
||||
| 23 | Completed |
Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Patients With Lysosomal Acid Lipase Deficiency
|
||||
| 24 | Completed |
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
|
||||
| 25 | Recruiting |
Genetic Studies of Lysosomal Storage Disorders
|
||||
| 26 | Completed |
Replagal Enzyme Replacement Therapy for Adults With Fabry Disease
|
||||
| 27 | Recruiting |
Biomarker for Metachromatic Leukodystrophy Disease
|
||||
| 28 | Completed |
Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
|
||||
| 29 | Recruiting |
Exploration of Immunity in Gaucher Disease
|
||||
| 30 | Terminated |
Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
|
||||
| 31 | Unknown † |
Detection of Fabry Disease in Chronic Renal Failure Patients in Area Provence - Alpes - Côte d'Azur
|
||||
| 32 | Completed |
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
|
||||
| 33 | Recruiting |
Trial in Children With Growth Failure Due to Early Onset Lysosomal Acid Lipase (LAL) Deficiency/Wolman Disease
|
||||
| 34 | Terminated |
Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102
|
||||
| 35 | Enrolling by invitation |
Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)
|
||||
| 36 | Unknown † |
Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis
|
||||
| 37 | Recruiting |
Physician Initiated Request for Migalastat in Individual Patients With Fabry Disease
|
||||
| 38 | Recruiting |
Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients
|
||||
| 39 | Recruiting |
Open-Label Phase 3 Long-Term Safety Study of Migalastat
|
||||
| 40 | Enrolling by invitation |
An Extension of a Phase 1/2, Open Label, Dose Ranging Study of PRX-102 in Adult Fabry Patients
|
† Indicates status has not been verified in more than two years

